ARTICLE | Company News
Chiron, Roche diagnostic news
September 13, 2004 7:00 AM UTC
The companies settled their dispute over licensing fees and royalties that CHIR asserted it was owed under a licensing deal related to U.S. Patent No. 6,531,276 covering nucleic acid testing (NAT) met...